167 related articles for article (PubMed ID: 8260362)
1. Pharmacokinetics of varying doses of nicotinamide and tumour radiosensitisation with carbogen and nicotinamide: clinical considerations.
Rojas A; Hodgkiss RJ; Stratford MR; Dennis MF; Johns H
Br J Cancer; 1993 Dec; 68(6):1115-21. PubMed ID: 8260362
[TBL] [Abstract][Full Text] [Related]
2. Carbogen and nicotinamide as radiosensitizers in a murine mammary carcinoma using conventional and accelerated radiotherapy.
Rojas A; Hirst VK; Calvert AS; Johns H
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):357-65. PubMed ID: 8567336
[TBL] [Abstract][Full Text] [Related]
3. Is sensitization with nicotinamide and carbogen dependent on nicotinamide concentration at the time of irradiation?
Rojas A; Stratford MR; Bentzen SM; Denekamp J
Int J Radiat Biol; 2004 Jul; 80(7):499-506. PubMed ID: 15360088
[TBL] [Abstract][Full Text] [Related]
4. Radiosensitisation in normal tissues with oxygen, carbogen or nicotinamide: therapeutic gain comparisons for fractionated x-ray schedules.
Rojas A; Vojnovic B; Johns H; Joiner MC; Martindale C; Fowler JF; Denekamp J
Radiother Oncol; 1996 Apr; 39(1):53-64. PubMed ID: 8735494
[TBL] [Abstract][Full Text] [Related]
5. Preclinical studies on how to deal with patient intolerance to nicotinamide and carbogen.
Horsman MR; Overgaard J
Radiother Oncol; 2004 Mar; 70(3):301-9. PubMed ID: 15064017
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of nicotinamide in cancer patients treated with accelerated radiotherapy: the experience of the Co-operative Group of Radiotherapy of the European Organization for Research and Treatment of Cancer.
Bernier J; Stratford MR; Denekamp J; Dennis MF; Bieri S; Hagen F; Kocagöncü O; Bolla M; Rojas A
Radiother Oncol; 1998 Aug; 48(2):123-33. PubMed ID: 9783883
[TBL] [Abstract][Full Text] [Related]
7. A therapeutic benefit from combining normobaric carbogen or oxygen with nicotinamide in fractionated X-ray treatments.
Kjellen E; Joiner MC; Collier JM; Johns H; Rojas A
Radiother Oncol; 1991 Oct; 22(2):81-91. PubMed ID: 1835542
[TBL] [Abstract][Full Text] [Related]
8. Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time.
Chaplin DJ; Horsman MR; Siemann DW
Br J Cancer; 1993 Aug; 68(2):269-73. PubMed ID: 8347481
[TBL] [Abstract][Full Text] [Related]
9. Radiosensitization of SCCVII tumours and normal tissues by nicotinamide and carbogen: analysis by micronucleus assay.
Ono K; Masunaga S; Akuta K; Akaboshi M; Abe M
Radiother Oncol; 1993 Aug; 28(2):162-7. PubMed ID: 8248558
[TBL] [Abstract][Full Text] [Related]
10. Reducing acute and chronic hypoxia in tumours by combining nicotinamide with carbogen breathing.
Horsman MR; Nordsmark M; Khalil AA; Hill SA; Chaplin DJ; Siemann DW; Overgaard J
Acta Oncol; 1994; 33(4):371-6. PubMed ID: 8018368
[TBL] [Abstract][Full Text] [Related]
11. Should carbogen and nicotinamide be given throughout the full course of fractionated radiotherapy regimens?
Rojas AM; Johns H; Fiat PR
Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1101-5. PubMed ID: 8262834
[TBL] [Abstract][Full Text] [Related]
12. Fractionated irradiation combined with carbogen breathing and nicotinamide of two human glioblastomas grafted in nude mice.
Sun LQ; Coucke PA; Mirimanoff RO; Buchegger F
Radiat Res; 2001 Jan; 155(1 Pt 1):26-31. PubMed ID: 11121212
[TBL] [Abstract][Full Text] [Related]
13. Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivo.
Chaplin DJ; Horsman MR; Aoki DS
Br J Cancer; 1991 Jan; 63(1):109-13. PubMed ID: 1846549
[TBL] [Abstract][Full Text] [Related]
14. Effects of the interaction between carbogen and nicotinamide on R3230 Ac tumor blood flow in Fischer 344 rats.
Braun RD; Lanzen JL; Turnage JA; Rosner G; Dewhirst MW
Radiat Res; 2001 May; 155(5):724-33. PubMed ID: 11302770
[TBL] [Abstract][Full Text] [Related]
15. Nicotinamide pharmacokinetics in humans and mice: a comparative assessment and the implications for radiotherapy.
Horsman MR; Høyer M; Honess DJ; Dennis IF; Overgaard J
Radiother Oncol; 1993 May; 27(2):131-9. PubMed ID: 8356223
[TBL] [Abstract][Full Text] [Related]
16. Nicotinamide as a repair inhibitor in vivo: studies using single and fractionated X-ray doses in mouse skin and kidneys.
Rojas A; Denekamp J; Johns H; Kjellen E; Tsang R; Nilsson P; Stratford MR; Dennis MF; Joiner MC
Radiat Res; 1996 Apr; 145(4):419-31. PubMed ID: 8600502
[TBL] [Abstract][Full Text] [Related]
17. Perfusion changes in the RIF-1 tumour and normal tissues after carbogen and nicotinamide, individually and combined.
Honess DJ; Bleehen NM
Br J Cancer; 1995 Jun; 71(6):1175-80. PubMed ID: 7779707
[TBL] [Abstract][Full Text] [Related]
18. Carbogen breathing with nicotinamide improves the oxygen status of tumours in patients.
Laurence VM; Ward R; Dennis IF; Bleehen NM
Br J Cancer; 1995 Jul; 72(1):198-205. PubMed ID: 7599052
[TBL] [Abstract][Full Text] [Related]
19. The radiation response of KHT sarcomas following nicotinamide treatment and carbogen breathing.
Siemann DW; Horsman MR; Chaplin DJ
Radiother Oncol; 1994 May; 31(2):117-22. PubMed ID: 8066190
[TBL] [Abstract][Full Text] [Related]
20. The modification of human tumour blood flow using pentoxifylline, nicotinamide and carbogen.
Sibtain A; Hill S; Goodchild K; Shah N; Saunders M; Hoskin PJ
Radiother Oncol; 2002 Jan; 62(1):69-76. PubMed ID: 11830314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
